Editorial: Agency in denial - Stem cell board lacks money, not issues [California]
By Sacramento Bee,
Sacramento Bee
| 08. 13. 2005
People who suffer a serious medical setback often can't come to grips with it. Paralyzed stroke victims, for instance, sometimes insist they can raise their arms when they can't.
Doctors call this disorder "denial syndrome". California's $3 billion stem cell research institute appears to be afflicted by it.
Lawsuits filed by opponents of embryonic stem cell research have prevented the state from issuing bonds for the Institute for Regenerative Medicine, putting the whole program in limbo. These lawsuits are hugely dispiriting to Californians who support stem cell research, but they are a reality, and they could delay the institute's research grants by one or two years.
Institute leaders need to make the most of this lull by settling issues that will continue to dog the institute over the next decade. Instead, Institute Chairman Robert Klein II continues to toot his horn and cry "full steam ahead!" even as his ship remains tethered to the dock.
The latest exercise in institutional denial came Aug. 3 in San Francisco, where the institute held the first meeting of its grants review committee. The...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...